Article Details

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

Retrieved on: 2018-04-29 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs. View article details on hiswai:

Excerpt

<div>San Diego's <b>Avalon Ventures</b> and Correlation Ventures, which were the founding investors, also joined the round, along with Boston's RA Capital Management, an earlier investor. The funding will be used to advance Synthorin IL-2 into early clinical studies by the first half of 2019, but is really intended to ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up